Lineage Therap(IL:LCTX)
ILA 346.60+20.90 (+6.42%)
IL:LCTX
Lineage Therap earnings date
ILA 346.60
At close:+20.90 (+6.42%)
Lineage Therap (LCTX) Q2 2022 Earnings Report
3 Followers
IL:LCTX Q2 2022 EPS Results
- Actual EPS
- -ILA 12.77
- Consensus EPS
- -ILA 10.54
- Beat/Miss
- Missed by -ILA 2.23
- One Year Ago EPS
- -ILA 9.58
IL:LCTX Q2 2022 Revenue Results
- Actual Revenue
- ILA 1.45B
- Expected Revenue
- ILA 1.18B
- Beat/Miss
- Beat by +ILA 277.43M
- YoY Revenue Growth
- +932.43%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/11/2022
- Time
- After Close
- Conference Call
- Thursday, August 11, 2022
IL:LCTX Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:LCTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -5.43- | 1.28 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -9.26-9.58 | -41.5 | 76.92% (+31.93) | |
| Aug 06, 2026 | 2026 (Q2) | -8.94-9.58 | -41.5 | 76.92% (+31.93) | |
| May 12, 2026 | 2026 (Q1) | -6.39-9.58 | -6.39 | -50.00% (-3.19) | |
| Mar 05, 2026 | 2025 (Q4) | -13.731.28 | -6.39 | 120.00% (+7.66) | |
| Nov 06, 2025 | 2025 (Q3) | -8.30-41.50 | -6.39 | -550.00% (-35.12) | |
| Aug 12, 2025 | 2025 (Q2) | -8.62-41.50 | -9.58 | -333.33% (-31.93) | |
| May 13, 2025 | 2025 (Q1) | -8.30-6.39 | -12.77 | 50.00% (+6.39) | |
| Mar 10, 2025 | 2024 (Q4) | -9.58-6.39 | -9.58 | 33.33% (+3.19) | |
| Nov 14, 2024 | 2024 (Q3) | -12.77-6.39 | -12.77 | 50.00% (+6.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
